'Disrupting Ccr2, which coordinates inflammatory macrophage recruitment to atria, or Spp1, which helps to drive inflammatory fibroblast activation by macrophages, ameliorated disease burden in HOMER mice, suggesting two potential immunotherapy targets for Afib patients.'

https://www.science.org/doi/10.1126/science.abq3061